FOCAL ONSET SEIZURES
Clinical trials for FOCAL ONSET SEIZURES explained in plain language.
Never miss a new study
Get alerted when new FOCAL ONSET SEIZURES trials appear
Sign up with your email to follow new studies for FOCAL ONSET SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New epilepsy pill shows promise in major trial
Disease control CompletedThis study tested a new medication called XEN1101 in 380 adults with focal-onset seizures (a type of epilepsy). Participants took the drug or a placebo alongside their usual seizure medicines. The goal was to see if XEN1101 could safely reduce how often seizures happen. Results w…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
New drug shows promise for stubborn seizures
Symptom relief CompletedThis study tested an experimental drug called RAP-219 in 30 adults with refractory focal epilepsy—seizures that don't respond well to standard treatments. All participants had a brain device already implanted to monitor seizures. The goal was to see if RAP-219 could safely reduce…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE2 • Sponsor: Rapport Therapeutics Inc. • Aim: Symptom relief
Last updated May 19, 2026 11:47 UTC